Literature DB >> 28106301

UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells.

Nuria Sánchez-Morgan1, Kathrin H Kirsch2, Philip C Trackman3, Gail E Sonenshein1.   

Abstract

The lysyl oxidase proenzyme propeptide region (LOX-PP) is a tumor suppressor protein whose mechanism of action is not completely understood. Here, the Ubiquitously expressed Transcript (UXT) was identified in a yeast two-hybrid assay with LOX-PP as bait and confirmed as a novel LOX-PP associating protein. UXT, a prefoldin-like protein, is ubiquitous in human and mouse. Since UXT modulates androgen receptor transcriptional activity in prostate cancer, we studied its role in breast cancer. Breast tumors and derived cell lines overexpressed UXT. UXT was able to associate with the estrogen receptor alpha (ER) and decrease its transcriptional activity and target gene expression. Conversely, UXT knockdown increased ER element-dependent transcriptional activity. Ectopic LOX-PP relocalized UXT to the cytoplasm and decreased its stability. UXT ubiquitination and depletion in the presence of LOX-PP was rescued by a proteasomal inhibitor. In summary, proteasome-mediated turnover of UXT upon interaction with LOX-PP releases repression of ER transcriptional activity. J. Cell. Biochem. 118: 2347-2356, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  BREAST CANCER; ESTROGEN RECEPTOR; LYSYL OXIDASE PROPEPTIDE; PROTEASOME; UXT

Mesh:

Substances:

Year:  2017        PMID: 28106301     DOI: 10.1002/jcb.25893

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  Genomic architecture and functional unit of mimicry supergene in female limited Batesian mimic Papilio butterflies.

Authors:  Shinya Komata; Rei Kajitani; Takehiko Itoh; Haruhiko Fujiwara
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-06-13       Impact factor: 6.671

Review 2.  Functions and Mechanisms of Pro-Lysyl Oxidase Processing in Cancers and Eye Pathologies with a Focus on Diabetic Retinopathy.

Authors:  Philip C Trackman; Yaser Peymanfar; Sayon Roy
Journal:  Int J Mol Sci       Date:  2022-05-03       Impact factor: 6.208

3.  Ubiquitous expressed transcript promotes tumorigenesis by acting as a positive modulator of the polycomb repressive complex 2 in clear cell renal cell carcinoma.

Authors:  Jin Zeng; Wei Xiang; Yucong Zhang; Chunhua Huang; Ke Chen; Zhiqiang Chen
Journal:  BMC Cancer       Date:  2019-09-03       Impact factor: 4.430

4.  UXT chaperone prevents proteotoxicity by acting as an autophagy adaptor for p62-dependent aggrephagy.

Authors:  Min Ji Yoon; Boyoon Choi; Eun Jin Kim; Jiyeon Ohk; Chansik Yang; Yeon-Gil Choi; Jinyoung Lee; Chanhee Kang; Hyun Kyu Song; Yoon Ki Kim; Jae-Sung Woo; Yongcheol Cho; Eui-Ju Choi; Hosung Jung; Chungho Kim
Journal:  Nat Commun       Date:  2021-03-29       Impact factor: 14.919

5.  UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis.

Authors:  Zhong-Feng Huang; Yu-Ling Tang; Zhao-Long Shen; Kai-Yan Yang; Kai Gao
Journal:  Mol Ther Oncolytics       Date:  2021-12-11       Impact factor: 7.200

6.  Insights into the structure and dynamics of lysyl oxidase propeptide, a flexible protein with numerous partners.

Authors:  Sylvain D Vallet; Adriana E Miele; Urszula Uciechowska-Kaczmarzyk; Adam Liwo; Bertrand Duclos; Sergey A Samsonov; Sylvie Ricard-Blum
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

7.  Inhibition of angiogenesis in endothelial cells by Human Lysyl oxidase propeptide.

Authors:  Ragavachetty Nagaraj Nareshkumar; Konerirajapuram Natarajan Sulochana; Karunakaran Coral
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

8.  The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.

Authors:  Valentine Spagnol; Caio A B Oliveira; Suzanne J Randle; Patrícia M S Passos; Camila R S T B Correia; Natália B Simaroli; Joice S Oliveira; Tycho E T Mevissen; Ana Carla Medeiros; Marcelo D Gomes; David Komander; Heike Laman; Felipe Roberti Teixeira
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-09-30       Impact factor: 3.770

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.